Skip to main content
. 2021 Dec 15;9(3):e01330-21. doi: 10.1128/Spectrum.01330-21

TABLE 2.

Characteristics of the study cohort who previously testes positive on PCR test

Full cohort Seronegative Seropositive Total P
n 1,296 532 1,828
Age (yrs) (median [IQR]) 47 [31-59]) 51 [40−61] 49 [34−59] <0.001
Male (%) 480 (37.0) 233 (43.8) 713 (39.0) 0.008
Body mass index (median [IQR]) 24.9 [22.4, 28.4] 25.6 [23.0, 29.1] 25.1 [22.6, 28.7] 0.003
Days between pos. PCR and POCT (median [IQR]) 58 [26, 188] 38 [23, 176] 46.5 [25, 187] 0.082
Missinga 693 331 1,024
Comorbidities (%)
Myocardial infarction 26 (2.0) 11 (2.1) 37 (2.0) 1.000
Stroke 31 (2.4) 17 (3.2) 48 (2.6) 0.415
Hypertension 257 (19.8) 129 (24.2) 386 (21.1) 0.041
Diabetes 67 (5.2) 38 (7.1) 105 (5.7) 0.124
Cancer 75 (5.8) 33 (6.2) 108 (5.9) 0.815
Rheumatoid arthritis 72 (5.6) 31 (5.8) 103 (5.6) 0.907
COPD 46 (3.5) 21 (3.9) 67 (3.7) 0.784
Asthma 202 (15.6) 84 (15.8) 286 (15.6) 0.970
Other chronic disease 211 (16.3) 84 (15.8) 295 (16.1) 0.850
Alcohol use (%) 144 (12.5) 56 (11.7) 22 (12.3) 0.708
Ever smoker (%) 607 (46.8) 278 (52.3) 885 (48.4) 0.040
a

Missing encompasses participants who did not have an available date of both positive PCR and POCT. Thus, days between positive PCR and POCT could not be calculated for these participants.